Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Apogee Therapeutics, Inc. Banner

Apogee Therapeutics, Inc.

APGE Stock Analysis

Page title

Section title

Breakdown
2022
2023
Net Income
-39.785m-83.985m
Depreciation & Amortization
0.0000.000
Change in Working Capital
9.815M6.105M
Operating Cash Flow
-16.427m-74.761m
Capital Expenditure
0.000-167.000k
Free Cash Flow
-16.427m-74.928m
Debt Repayment
0.0000.000
Dividends Paid
0.0000.000
Common Stock Issued
168.317M315.391M
Common Stock Repurchased
0.0000.000
Net Change in Cash
-16.243m-33.574m